CSU management requires more effective treatments and a deeper understanding of disease mechanisms to address unmet needs.
Current therapies often do not provide complete symptom relief, highlighting the demand for novel therapeutic options.
Advancements in biologics and personalized medicine are shaping the future of CSU management, aiming to improve patient outcomes.
Research is focused on identifying biomarkers for better diagnosis and treatment stratification in CSU.
SHOW MORE
Panelists discuss the unmet needs in chronic spontaneous urticaria (CSU) management, highlighting the evolution of the field toward more personalized and effective treatment strategies to address refractory symptoms.